Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent

Desborough, Michael J. R.; Mitchell, Joanne L.; Whitworth, Polly; Al Juwaiser, Ashifa; Sage, Tanya; Kriek, Neline; Little, Gemma; Vaiyapuri, Sakthivel; Gibbins, Jonathan M.; Bye, Alexander P.

Download

[thumbnail of HAEMATOL-2025-289179v3-Bye.pdf]

Text
- Accepted Version
· Restricted to Repository staff only
· The Copyright of this document has not been checked yet. This may affect its availability.

Advice

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Tools

Lists

Desborough, M. J. R., Mitchell, J. L., Whitworth, P., Al Juwaiser, A., Sage, T., Kriek, N., Little, G. ORCID: https://orcid.org/0000-0001-9810-4358, Vaiyapuri, S. ORCID: https://orcid.org/0000-0002-6006-6517, Gibbins, J. M. ORCID: https://orcid.org/0000-0002-0372-5352 and Bye, A. P. ORCID: https://orcid.org/0000-0002-2061-2253 (2026) Recombinant von Willebrand Factor (vonicog alfa) reduces platelet inhibition caused by antiplatelet drugs and has potential as an acute haemostatic agent. Haematologica. ISSN 1592-8721 (In Press)

Item Type	Article
URI	https://centaur.reading.ac.uk/id/eprint/127627
Refereed	Yes
Divisions	Life Sciences > School of Biological Sciences > Biomedical Sciences Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
Publisher	Ferrata Storti Foundation
Download/View statistics	View download statistics for this item